Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Appointed director
CC transcript
Appointed CFO

GILEAD SCIENCES, INC. (GILD) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/29/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/11/2023 4 Patterson Sandra (SVP, Controllership) has filed a Form 4 on GILEAD SCIENCES, INC.
Txns: Paid exercise price by delivering 1,306 shares @ $80, valued at $104.5k
Exercised 4,484 restricted stock units @ $0
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/30/2023 4 Lofton Kevin E (Director) has filed a Form 4 on GILEAD SCIENCES, INC.
Txns: Granted 31 options to buy @ $0
06/30/2023 4 GILEAD SCIENCES, INC. (10% Owner) has filed a Form 4 on Arcus Biosciences, Inc.
Txns: Bought 1,010,000 shares @ $19.26, valued at $19.5M
06/28/2023 4 GILEAD SCIENCES, INC. (10% Owner) has filed a Form 4 on Allovir, Inc.
Txns: Bought 2,930,870 shares @ $3.75, valued at $11M
06/12/2023 4 Patterson Sandra (SVP, Controllership) has filed a Form 4 on GILEAD SCIENCES, INC.
Txns: Paid exercise price by delivering 153 shares @ $78.12, valued at $12k
Exercised 517 restricted stock units @ $0
06/12/2023 4 Parsey Merdad (Chief Medical Officer) has filed a Form 4 on GILEAD SCIENCES, INC.
Txns: Paid exercise price by delivering 1,294 shares @ $78.12, valued at $101.1k
Exercised 2,779 restricted stock units @ $0
06/12/2023 4 O'Day Daniel Patrick (Chairman & CEO) has filed a Form 4 on GILEAD SCIENCES, INC.
Txns: Paid exercise price by delivering 3,409 shares @ $78.12, valued at $266.3k
Exercised 7,346 restricted stock units @ $0
06/12/2023 4 Mercier Johanna (Chief Commercial Officer) has filed a Form 4 on GILEAD SCIENCES, INC.
Txns: Paid exercise price by delivering 1,272 shares @ $78.12, valued at $99.4k
Exercised 2,730 restricted stock units @ $0
06/12/2023 4 Dickinson Andrew D (CFO) has filed a Form 4 on GILEAD SCIENCES, INC.
Txns: Paid exercise price by delivering 1,219 shares @ $78.12, valued at $95.2k
Exercised 2,618 restricted stock units @ $0
05/04/2023 4 Kramer Kelly A. (Director) has filed a Form 4 on GILEAD SCIENCES, INC.
Txns: Granted 1,887 restricted stock units @ $0
Granted 10,173 options to buy @ $79.45, valued at $808.2k
05/04/2023 4 BARTON JACQUELINE K (Director) has filed a Form 4 on GILEAD SCIENCES, INC.
Txns: Granted 1,887 shares @ $0
Granted 10,173 options to buy @ $79.45, valued at $808.2k
05/04/2023 4 Bluestone Jeffrey (Director) has filed a Form 4 on GILEAD SCIENCES, INC.
Txns: Granted 1,887 restricted stock units @ $0
Granted 10,173 options to buy @ $79.45, valued at $808.2k
05/04/2023 4 Horning Sandra (Director) has filed a Form 4 on GILEAD SCIENCES, INC.
Txns: Granted 1,887 shares @ $0
Granted 10,173 options to buy @ $79.45, valued at $808.2k
05/04/2023 4 Lofton Kevin E (Director) has filed a Form 4 on GILEAD SCIENCES, INC.
Txns: Granted 1,887 shares @ $0
Granted 10,173 options to buy @ $79.45, valued at $808.2k
05/04/2023 4 Rodriguez Javier (Director) has filed a Form 4 on GILEAD SCIENCES, INC.
Txns: Granted 1,887 shares @ $0
Granted 10,173 options to buy @ $79.45, valued at $808.2k
05/04/2023 4 MANWANI HARISH (Director) has filed a Form 4 on GILEAD SCIENCES, INC.
Txns: Granted 1,887 shares @ $0
Paid exercise price by delivering 368 shares @ $79.45, valued at $29.2k
Granted 10,173 options to buy @ $79.45, valued at $808.2k
05/04/2023 4 WELTERS ANTHONY (Director) has filed a Form 4 on GILEAD SCIENCES, INC.
Txns: Granted 1,887 shares @ $0
Granted 10,173 options to buy @ $79.45, valued at $808.2k
05/02/2023 4 Lofton Kevin E (Director) has filed a Form 4 on GILEAD SCIENCES, INC.
Txns: Gifted 12,868 shares @ $0
03/31/2023 4 Lofton Kevin E (Director) has filed a Form 4 on GILEAD SCIENCES, INC.
Txns: Granted 29 options to buy @ $0
03/14/2023 4 Parsey Merdad (Chief Medical Officer) has filed a Form 4 on GILEAD SCIENCES, INC.
Txns: Sold 6,126 shares @ $78.99, valued at $483.9k
03/14/2023 4 O'Day Daniel Patrick (Chairman & CEO) has filed a Form 4 on GILEAD SCIENCES, INC.
Txns: Paid exercise price by delivering 14,017 shares @ $79.5, valued at $1.1M
Exercised 19,488 restricted stock units @ $0
Exercised 10,800 restricted stock units @ $0
Granted 47,170 restricted stock units @ $0
Granted 215,095 options to buy @ $79.5, valued at $17.1M
03/13/2023 4 Parsey Merdad (Chief Medical Officer) has filed a Form 4 on GILEAD SCIENCES, INC.
Txns: Paid exercise price by delivering 5,328 shares @ $79.5, valued at $423.6k
Exercised 3,455 restricted stock units @ $0
Exercised 7,999 restricted stock units @ $0
Granted 16,665 restricted stock units @ $0
Granted 76,000 options to buy @ $79.5, valued at $6M
03/13/2023 4 Patterson Sandra (SVP, Controllership) has filed a Form 4 on GILEAD SCIENCES, INC.
Txns: Paid exercise price by delivering 801 shares @ $79.5, valued at $63.7k
Exercised 1,601 restricted stock units @ $0
Exercised 1,320 restricted stock units @ $0
Granted 6,130 restricted stock units @ $0
Granted 10,405 options to buy @ $79.5, valued at $827.2k
03/13/2023 4 Mercier Johanna (Chief Commercial Officer) has filed a Form 4 on GILEAD SCIENCES, INC.
Txns: Paid exercise price by delivering 5,116 shares @ $79.5, valued at $406.7k
Exercised 3,025 restricted stock units @ $0
Exercised 7,951 restricted stock units @ $0
Granted 16,350 restricted stock units @ $0
Granted 74,565 options to buy @ $79.5, valued at $5.9M
03/13/2023 4 Dickinson Andrew D (CFO) has filed a Form 4 on GILEAD SCIENCES, INC.
Txns: Paid exercise price by delivering 4,849 shares @ $79.5, valued at $385.5k
Exercised 3,025 restricted stock units @ $0
Exercised 7,394 restricted stock units @ $0
Granted 16,350 restricted stock units @ $0
Granted 74,565 options to buy @ $79.5, valued at $5.9M
03/13/2023 4 Telman Deborah H (EVP, Corporate Affairs & GC) has filed a Form 4 on GILEAD SCIENCES, INC.
Txns: Granted 10,220 restricted stock units @ $0
Granted 46,605 options to buy @ $79.5, valued at $3.7M
03/10/2023 4 Lofton Kevin E (Director) has filed a Form 4 on GILEAD SCIENCES, INC.
Txns: Exercised 8,442 options to buy @ $52.38, valued at $442.2k
03/09/2023 3 Patterson Sandra (SVP, Controllership) has filed a Form 3 on GILEAD SCIENCES, INC.
03/02/2023 4 Parsey Merdad (Chief Medical Officer) has filed a Form 4 on GILEAD SCIENCES, INC.
Txns: Sold 12,984 shares @ $79.9619, valued at $1M
03/02/2023 4 O'Day Daniel Patrick (Chairman & CEO) has filed a Form 4 on GILEAD SCIENCES, INC.
Txns: Paid exercise price by delivering 4,842 shares @ $79.59, valued at $385.4k
Exercised 11,362 restricted stock units @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy